ChengDa Pharmaceuticals Co., Ltd. (SHE:301201)
China · Delayed Price · Currency is CNY 25.42
0.00 (0.00%)
At close: Oct 23, 2026
ChengDa Pharmaceuticals Market Cap
ChengDa Pharmaceuticals has a market cap or net worth of 3.85 billion as of October 23, 2026. It is the 13,429th most valuable company in the world and the 3,431st biggest in China. Its market cap has decreased by 25.19% in one year.
Market Cap
3.85B
Enterprise Value
2.92B
Revenue
479.41M
Global Rank
Country Rank
#3,431 China
PE Ratio
n/a
ChartMarket Cap Chart
Since January 20, 2022, ChengDa Pharmaceuticals's market cap has decreased from 12.43B to 3.85B, a decrease of -69.02%. That is a compound annual growth rate of -21.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 3.85B | -37.54% |
| Dec 31, 2025 | 6.16B | 101.68% |
| Dec 31, 2024 | 3.06B | -22.31% |
| Dec 29, 2023 | 3.93B | -19.91% |
| Dec 30, 2022 | 4.91B | -60.48% |
| Jan 20, 2022 | 12.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zhongzhu Healthcare Holding Co.,Ltd | 4.00B |
| LanZhou Foci Pharmaceutical | 3.94B |
| Jiangsu Lianhuan Pharmaceutical | 3.91B |
| Jinling Pharmaceutical Company | 3.87B |
| Nanjing Hicin Pharmaceutical | 3.85B |
| Sinotherapeutics | 3.83B |
| Hunan Hansen Pharmaceutical | 3.81B |
| Hainan Shuangcheng Pharmaceuticals | 3.76B |